Sort by
Refine Your Search
-
Paulo, Brazil), and at the animal facilities. To be eligible, candidates must have: - Completed a PhD in any area of the biomedical or health sciences; - Availability to dedicate full-time and work
-
). Preferred qualifications: PhD in Sport Sciences or related fields; research experience with hypoxia studies (human and animal models); availability for short travels to collaborate with partner laboratories
-
the last 5 years; 2) PhD diploma or proof of doctoral defense; 3) Cover letter showing the pre-requisites required; 4) Two letters of reference; The application deadline is October, 12th, 2025 More
-
analyses), collaborating in student supervision, seeking research collaborations, contributing to scientific dissemination, and preparing reports and manuscripts. Requirements: • PhD in Biomedical Sciences
-
) Mechanistic understanding of ncRNAs in host-parasite interactions and parasite metastasis. Candidates must hold a PhD in Molecular Biology, Cell Biology, Genetics, or Biochemistry and must have prior knowledge
-
. Letter of recommendation from PhD advisor. Conditions: Monthly fellowship: R$ 12,570.00; Technical Reserve: 10% of annual amount (research-related expenses); Open to Brazilian and international candidates
-
transmembrane domains of VirB6 and VirB8, followed by structural/biophysical studies using biochemistry, NMR spectroscopy, and electron microscopy (Cryo-EM or negative staining). Candidates must hold a PhD in
-
/function and engineering of luciferases; applications in biosensors, bioassays, and environmental bioindication,” which involves gene target selection, cloning, expression, purification, and functional
-
4 Sep 2025 Job Information Organisation/Company FAPESP - São Paulo Research Foundation Research Field Environmental science Researcher Profile Established Researcher (R3) Country Brazil Application Deadline 15 Oct 2025 - 23:59 (UTC) Type of Contract To be defined Job Status Not Applicable Is the...
-
cancer. CRIO is an Engineering Research Center (ERC) supported by the São Paulo Research Foundation (FAPESP) and GSK, the result of a partnership between the Albert Einstein Institute for Education and